Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD38 antibodies and formulations

Anti-CD38 antibodies and formulations

US Patent 11655302 · Granted May 23, 2023

Estimated economic value: $27,452,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-GPRC5D antibodies and compositions2025
Anti-GPRC5D antibodies and compositions2025
FGF-21 formulations2025
Anti-CHIKV antibodies and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-eng2025
PseudoFab-based multispecific binding proteins2023
Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD1232023
Trispecific binding proteins, methods, and uses thereof2023
Trispecific binding proteins, methods, and uses thereof2023
Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of u2022